Anaplasia Rediviva
- SIR PETER MEDAWAR, D.Sc., F.R.S., F.A.C.P.(Hon.)
Abstract
Anaplasia refers to the apparent retrogression toward an embryonic state that occurs in some human and animal tumors, the consequence, presumably, of a derepression of genes that would normally have been switched off in the course of development. The fetal substances newly formed in tumors are identified immunologically and are therefore referred to as "antigens." Some such antigens, for example, carcinoembryonic antigen and alpha-fetoprotein, and blood-group precursor substances have great promise diagnostically but play no known part in resistance to malignant growth. The reawakened fetal antigens that are of special interest and importance are those that are capable of arousing cell-mediated immunity and thus may contribute to antitumor immunity. Modern research, therefore, rehabilitates an etiologic notion earlier thought to have been discredited.
Article and Author Information
-
▸From the Transplantation Biology Section, Clinical Research Centre; Harrow, Middlesex, England.
-
▸Requests for reprints should be addressed to Sir Peter Medawar, D.Sc.; Transplantation Biology Section, Clinical Research Centre, Watford Road; Harrow, Middlesex HA1 3UJ, England.
RSS Feeds









